Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia

Journal of Vascular Surgery

Volumn 50, Issue 4, 2009, Pages 769-775

  Schanzer, Andres ^a   Goodney, Philip P ^b   Li, Youfu ^a   Eslami, Mohammad ^a   Cronenwett, Jack ^b   Messina, Louis ^a   Conte, Michael S ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; AUTOGRAFT; CAROTID ARTERY DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; LEG REVASCULARIZATION; LIMB ISCHEMIA; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL RATE; VALIDATION STUDY; VEIN GRAFT;

AGED; AGED, 80 AND OVER; AMPUTATION; CRITICAL ILLNESS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; GRAFT SURVIVAL; HUMANS; INGUINAL CANAL; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LEG; LIMB SALVAGE; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR PATENCY; VASCULAR SURGICAL PROCEDURES;

EID: 70349333870     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.05.055     Document Type: Article

References (25)

1. Criqui M.H., Langer R.D., Fronek A., Feigelson H.S., Klauber M.R., McCann T.J., and Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326 (1992) 381-386
2. McKenna M., Wolfson S., and Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 87 (1991) 119-128
3. Murabito J.M., Evans J.C., Nieto K., Larson M.G., Levy D., and Wilson P.W. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 143 (2002) 961-965
4. Howell M.A., Colgan M.P., Seeger R.W., Ramsey D.E., and Sumner D.S. Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: a six-year follow-up study. J Vasc Surg 9 (1989) 691-696 discussion 696-7
5. Adam D.J., Beard J.D., Cleveland T., Bell J., Bradbury A.W., Forbes J.F., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366 (2005) 1925-1934
6. Stoyioglou A., and Jaff M.R. Medical treatment of peripheral arterial disease: a comprehensive review. J Vasc Interv Radiol 15 (2004) 1197-1207
7. Steg P.G., Bhatt D.L., Wilson P.W., D'Agostino Sr. R., Ohman E.M., Röther J., et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297 (2007) 1197-1206
8. Caro J., Migliaccio-Walle K., Ishak K.J., and Proskorovsky I. The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database. BMC Cardiovasc Disord 5 (2005) 14
9. DeRubertis B.G., Faries P.L., McKinsey J.F., Chaer R.A., Pierce M., Karwowski J., et al. Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions. Ann Surg 246 (2007) 415-422 discussion 422-4
10. Schanzer A., Mega J., Meadows J., Samson R.H., Bandyk D.F., and Conte M.S. Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg 48 (2008) 1464-1471
11. Conte M.S., Lorenz T.J., Bandyk D.F., Clowes A.W., Moneta G.L., and Seely B.L. Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc Endovascular Surg 39 (2005) 15-23
12. Cronenwett J.L., Likosky D.S., Russell M.T., Eldrup-Jorgensen J., Stanley A.C., Nolan B.W., and VSGNNE. A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSGNNE). J Vasc Surg 46 (2007) 1093-1101 discussion 1101-2
13. Conte M.S., Bandyk D.F., Clowes A.W., Moneta G.L., Seely L., Lorenz T.J., et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 43 (2006) 742-751 discussion 751
14. Goodney P.P., Likosky D.S., Cronenwett J.L., and Vascular Study Group of Northern New England. Factors associated with stroke or death after carotid endarterectomy in Northern New England. J Vasc Surg 48 (2008) 1139-1145
15. Abou-Zamzam Jr. A.M., Lee R.W., Moneta G.L., Taylor Jr. L.M., and Porter J.M. Functional outcome after infrainguinal bypass for limb salvage. J Vasc Surg 25 (1997) 287-295 discussion 295-7
16. Nguyen L.L., Moneta G.L., Conte M.S., Bandyk D.F., Clowes A.W., Seely B.L., and PREVENT III Investigators. Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg 44 (2006) 977-983 discussion 983-4
17. Thorsen H., McKenna S., Tennant A., and Holstein P. Nottingham health profile scores predict the outcome and support aggressive revascularisation for critical ischaemia. Eur J Vasc Endovasc Surg 23 (2002) 495-499
18. Owens C.D., Ho K.J., Kim S., Schanzer A., Lin J., Matros E., et al. Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. J Vasc Surg 45 (2007) 944-952
19. Schanzer A., Hevelone N., Owens C.D., Belkin M., Bandyk D.F., Clowes A.W., et al. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg 46 (2007) 1180-1190 discussion 1190
20. Khuri S.F., Daley J., Henderson W., Barbour G., Lowry P., Irvin G., et al. The National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment of the quality of surgical care. J Am Coll Surg 180 (1995) 519-531
21. Khuri S.F., Daley J., Henderson W., Hur K., Demakis J., Aust J.B., et al. The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. Ann Surg 228 (1998) 491-507
22. O'Grady M.A., Gitelson E., Swaby R.F., Goldstein L.J., Sein E., Keeley P., et al. Development and implementation of a medical oncology quality improvement tool for a regional community oncology network: the Fox Chase Cancer Center Partners initiative. J Natl Compr Canc Netw 5 (2007) 875-882
23. Scott I.A., Eyeson-Annan M.L., Huxley S.L., and West M.J. Optimising care of acute myocardial infarction: results of a regional quality improvement project. J Qual Clin Pract 20 (2000) 12-19
24. Holman W.L., Sansom M., Kiefe C.I., Peterson E.D., Hubbard S.G., Delong J.F., and Allman R.M. Alabama coronary artery bypass grafting project: results from phase II of a statewide quality improvement initiative. Ann Surg 239 (2004) 99-109
25. O'Connor G.T., Quinton H.B., Kahn R., Robichaud P., Maddock J., Lever T., et al. Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pediatr Pulmonol 33 (2002) 99-105